About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 2,381–2,390 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 2,352 |
CONTROL ENGINEERING PRACTICE CONTROL ENG PRACT |
0967-0661 1873-6939 |
4.600 | 4.500 | Q1 | 21/89 | PERGAMON-ELSEVIER SCIENCE LTD |
| 2,352 |
Current Addiction Reports CURR ADDICT REP |
N/A 2196-2952 |
4.600 | 5.200 | Q1 | May-58 | SPRINGERNATURE |
| 2,352 |
CURRENT ALLERGY AND ASTHMA REPORTS CURR ALLERGY ASTHM R |
1529-7322 1534-6315 |
4.600 | 5.100 | Q2 | Oct-39 | CURRENT MEDICINE GROUP |
| 2,352 |
Current Issues in Tourism CURR ISSUES TOUR |
1368-3500 1747-7603 |
4.600 | 6.300 | Q1 | 24/139 | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD |
| 2,352 |
CURRENT OPINION IN LIPIDOLOGY CURR OPIN LIPIDOL |
0957-9672 1473-6535 |
4.600 | 4.100 | Q1 | 16/98 | LIPPINCOTT WILLIAMS & WILKINS |
| 2,352 |
Data Science and Engineering DATA SCI ENG |
2364-1185 2364-1541 |
4.600 | 3.700 | Q1 | 21/147 | SPRINGERNATURE |
| 2,352 |
Earth System Governance EARTH SYST GOV-NETH |
2589-8116 2589-8116 |
4.600 | 6.300 | Q1 | 3/169 | ELSEVIER |
| 2,352 |
Emerging Markets Review EMERG MARK REV |
1566-0141 1873-6173 |
4.600 | 5.100 | Q1 | 58/617 | ELSEVIER |
| 2,352 |
Endocrine Practice ENDOCR PRACT |
1530-891X 1934-2403 |
4.600 | 4.100 | Q1 | 43/191 | ELSEVIER INC |
| 2,352 |
ENDOCRINE-RELATED CANCER ENDOCR-RELAT CANCER |
1351-0088 1479-6821 |
4.600 | 4.200 | Q1 | 43/191 | BIOSCIENTIFICA LTD |